Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C142789
Created by
admin on Sat Dec 16 00:46:49 GMT 2023 , Edited by admin on Sat Dec 16 00:46:49 GMT 2023
|
||
|
EMA ASSESSMENT REPORTS |
SOMAVERT (AUTHORIZED: ACROMEGALY)
Created by
admin on Sat Dec 16 00:46:49 GMT 2023 , Edited by admin on Sat Dec 16 00:46:49 GMT 2023
|
||
|
FDA ORPHAN DRUG |
105097
Created by
admin on Sat Dec 16 00:46:49 GMT 2023 , Edited by admin on Sat Dec 16 00:46:49 GMT 2023
|
||
|
NDF-RT |
N0000190119
Created by
admin on Sat Dec 16 00:46:49 GMT 2023 , Edited by admin on Sat Dec 16 00:46:49 GMT 2023
|
||
|
WHO-ATC |
H01AX01
Created by
admin on Sat Dec 16 00:46:49 GMT 2023 , Edited by admin on Sat Dec 16 00:46:49 GMT 2023
|
||
|
WHO-VATC |
QH01AX01
Created by
admin on Sat Dec 16 00:46:49 GMT 2023 , Edited by admin on Sat Dec 16 00:46:49 GMT 2023
|
||
|
EU-Orphan Drug |
EU/3/01/023
Created by
admin on Sat Dec 16 00:46:49 GMT 2023 , Edited by admin on Sat Dec 16 00:46:49 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
KK-71
Created by
admin on Sat Dec 16 00:46:49 GMT 2023 , Edited by admin on Sat Dec 16 00:46:49 GMT 2023
|
PRIMARY | |||
|
C406545
Created by
admin on Sat Dec 16 00:46:49 GMT 2023 , Edited by admin on Sat Dec 16 00:46:49 GMT 2023
|
PRIMARY | |||
|
N824AOU5XV
Created by
admin on Sat Dec 16 00:46:49 GMT 2023 , Edited by admin on Sat Dec 16 00:46:49 GMT 2023
|
PRIMARY | |||
|
Pegvisomant
Created by
admin on Sat Dec 16 00:46:49 GMT 2023 , Edited by admin on Sat Dec 16 00:46:49 GMT 2023
|
PRIMARY | |||
|
N0000010267
Created by
admin on Sat Dec 16 00:46:49 GMT 2023 , Edited by admin on Sat Dec 16 00:46:49 GMT 2023
|
PRIMARY | Growth Hormone Receptor Antagonists [MoA] | ||
|
PEGVISOMANT
Created by
admin on Sat Dec 16 00:46:49 GMT 2023 , Edited by admin on Sat Dec 16 00:46:49 GMT 2023
|
PRIMARY | |||
|
SUB03668MIG
Created by
admin on Sat Dec 16 00:46:49 GMT 2023 , Edited by admin on Sat Dec 16 00:46:49 GMT 2023
|
PRIMARY | |||
|
CHEMBL1201515
Created by
admin on Sat Dec 16 00:46:49 GMT 2023 , Edited by admin on Sat Dec 16 00:46:49 GMT 2023
|
PRIMARY | |||
|
7485
Created by
admin on Sat Dec 16 00:46:49 GMT 2023 , Edited by admin on Sat Dec 16 00:46:49 GMT 2023
|
PRIMARY | |||
|
278739
Created by
admin on Sat Dec 16 00:46:49 GMT 2023 , Edited by admin on Sat Dec 16 00:46:49 GMT 2023
|
PRIMARY | RxNorm | ||
|
7941
Created by
admin on Sat Dec 16 00:46:49 GMT 2023 , Edited by admin on Sat Dec 16 00:46:49 GMT 2023
|
PRIMARY | |||
|
N824AOU5XV
Created by
admin on Sat Dec 16 00:46:49 GMT 2023 , Edited by admin on Sat Dec 16 00:46:49 GMT 2023
|
PRIMARY | |||
|
5015
Created by
admin on Sat Dec 16 00:46:49 GMT 2023 , Edited by admin on Sat Dec 16 00:46:49 GMT 2023
|
PRIMARY | |||
|
m8448
Created by
admin on Sat Dec 16 00:46:49 GMT 2023 , Edited by admin on Sat Dec 16 00:46:49 GMT 2023
|
PRIMARY | Merck Index | ||
|
C61881
Created by
admin on Sat Dec 16 00:46:49 GMT 2023 , Edited by admin on Sat Dec 16 00:46:49 GMT 2023
|
PRIMARY | |||
|
100000089425
Created by
admin on Sat Dec 16 00:46:49 GMT 2023 , Edited by admin on Sat Dec 16 00:46:49 GMT 2023
|
PRIMARY | |||
|
218620-50-9
Created by
admin on Sat Dec 16 00:46:49 GMT 2023 , Edited by admin on Sat Dec 16 00:46:49 GMT 2023
|
PRIMARY | |||
|
DB00082
Created by
admin on Sat Dec 16 00:46:49 GMT 2023 , Edited by admin on Sat Dec 16 00:46:49 GMT 2023
|
PRIMARY |
ACTIVE MOIETY